FDA has approved MOVANTIKsup/sup (naloxegol) tablets as the first once-daily oral peripherally-acting mu-opioid receptor antagonist drug for the treatment of opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain. Opioids play an important role in chronic pain relief and millions of patients are treated with them in the United States each year. They work by binding to mu-receptors in the central nervous system, ...Saturday, 1 November 2014
New Treatment for Opioid Induced Constipation in Patients With Chronic Non-cancer Pain
FDA has approved MOVANTIKsup/sup (naloxegol) tablets as the first once-daily oral peripherally-acting mu-opioid receptor antagonist drug for the treatment of opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain. Opioids play an important role in chronic pain relief and millions of patients are treated with them in the United States each year. They work by binding to mu-receptors in the central nervous system, ...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment